fda warning bpc-157 not approved safety concerns
Size:250 ml BPC 157 Peptides | Madison Medical New Jersey pharmaceutical-grade https://cdn.shopify.com/s/files/1/2461/7623/files/what-are-the-side-effects-and-risks-of-bpc-157.png?v=1784033432 Oral administration faces hepatic first-pass metabolism, reducing bioavailability to approximately 40–50% of subcutaneous routes, but offers convenience for longer-term studies where daily injections create compliance challenges